ATE279940T1 - Behandlung und prävention von helicobacter- infektionen - Google Patents
Behandlung und prävention von helicobacter- infektionenInfo
- Publication number
- ATE279940T1 ATE279940T1 AT95920717T AT95920717T ATE279940T1 AT E279940 T1 ATE279940 T1 AT E279940T1 AT 95920717 T AT95920717 T AT 95920717T AT 95920717 T AT95920717 T AT 95920717T AT E279940 T1 ATE279940 T1 AT E279940T1
- Authority
- AT
- Austria
- Prior art keywords
- prevention
- treatment
- helicobacter infections
- helicobacter
- catalase enzyme
- Prior art date
Links
- 206010019375 Helicobacter infections Diseases 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 208000028861 Helicobacter pylori infectious disease Diseases 0.000 title 1
- 102000016938 Catalase Human genes 0.000 abstract 2
- 108010053835 Catalase Proteins 0.000 abstract 2
- 241000589989 Helicobacter Species 0.000 abstract 1
- 241000590017 Helicobacter felis Species 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0065—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPM6124A AUPM612494A0 (en) | 1994-06-08 | 1994-06-08 | Treatment or prevention of helicobacter infection |
PCT/AU1995/000335 WO1995033482A1 (en) | 1994-06-08 | 1995-06-08 | Treatment and prevention of helicobacter infection |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE279940T1 true ATE279940T1 (de) | 2004-11-15 |
Family
ID=3780694
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95920717T ATE279940T1 (de) | 1994-06-08 | 1995-06-08 | Behandlung und prävention von helicobacter- infektionen |
Country Status (9)
Country | Link |
---|---|
US (3) | US6005090A (de) |
EP (1) | EP0771214B1 (de) |
JP (1) | JPH10500958A (de) |
KR (1) | KR100368475B1 (de) |
AT (1) | ATE279940T1 (de) |
AU (1) | AUPM612494A0 (de) |
DE (1) | DE69533673T2 (de) |
NZ (1) | NZ287385A (de) |
WO (1) | WO1995033482A1 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6290962B1 (en) * | 1992-11-03 | 2001-09-18 | Oravax, Inc. | Urease-based vaccine and treatment for helicobacter infection |
AUPM399594A0 (en) * | 1994-02-21 | 1994-03-17 | Csl Limited | Antigenic preparation for treatment or prevention of helicobacter infection |
AUPM612494A0 (en) | 1994-06-08 | 1994-06-30 | Csl Limited | Treatment or prevention of helicobacter infection |
ATE229978T1 (de) * | 1994-07-01 | 2003-01-15 | Chiron Corp | Helicobacter proteine und impstoffe |
EP0745674B1 (de) * | 1995-06-02 | 2006-07-05 | Eisai Co., Ltd. | Helicobacter Polypeptide, deren Herstellung und Verwendung |
WO1997025429A1 (en) * | 1996-01-04 | 1997-07-17 | Rican Limited | Helicobacter pylori bacterioferritin |
US6551779B1 (en) | 1996-05-31 | 2003-04-22 | Tosiro Sugiyama | Helicobactor catalase nucleotide sequences, their production and use |
US5939300A (en) * | 1996-07-03 | 1999-08-17 | Diversa Corporation | Catalases |
JP3430853B2 (ja) * | 1997-04-11 | 2003-07-28 | 株式会社ゲン・コーポレーション | 胃炎、胃潰瘍および十二指腸潰瘍の予防剤並びに治療剤 |
BR9809426A (pt) * | 1997-04-30 | 2000-06-13 | Merieux Oravax | Composição de vacina anti-helicobacter para uso pela via sistêmica subdiafragmática e método de imunização mucosal/parenteral combinado |
US6599509B2 (en) * | 1997-09-02 | 2003-07-29 | Massachusetts Institute Of Technology | Compositions and methods comprising helicobacter antigens for treatment and prevention of inflammatory bowel disease |
US20020151462A1 (en) * | 1998-02-19 | 2002-10-17 | Ling Lissolo | Helicobacter pylori membrane proteins |
US6585975B1 (en) * | 1998-04-30 | 2003-07-01 | Acambis, Inc. | Use of Salmonella vectors for vaccination against helicobacter infection |
US6576244B1 (en) * | 1998-06-19 | 2003-06-10 | Acambis, Inc. | LT and CT in parenteral immunization methods against helicobacter infection |
DK1232392T3 (da) * | 1999-10-12 | 2003-07-28 | Connex Ges Zur Optimierung Von | Forbedret fremgangsmåde til påvisning af syreresistente bakterier af slægten Helicobacter i afføring |
AU772513B2 (en) * | 1999-10-15 | 2004-04-29 | Csl Limited | Polypeptide fragments comprising C-terminal portion of helicobacter catalase |
AUPQ347199A0 (en) * | 1999-10-15 | 1999-11-11 | Csl Limited | Novel polypeptide fragments |
CN1195869C (zh) * | 1999-10-29 | 2005-04-06 | 若素制药株式会社 | 单克隆抗体、杂交瘤、免疫测定法和诊断试剂盒 |
CA2414846A1 (en) * | 2000-07-05 | 2002-01-24 | Merieux Oravax | Immunological combinations for prophylaxis and therapy of helicobacter pylori infection |
US20020107368A1 (en) * | 2000-12-07 | 2002-08-08 | Jing-Hui Tian | Helicobacter proteins, gene sequences and uses thereof |
CA2458854A1 (en) * | 2001-08-31 | 2003-03-06 | Chiron Srl | Helicobacter pylori vaccination |
CA2733836A1 (en) * | 2011-03-09 | 2012-09-09 | Coorga International Holding Ltd. | Oral dietary supplementation for addressing of human canities |
US9878020B2 (en) * | 2011-04-07 | 2018-01-30 | Histapharm Inc. | Oral enzyme compositions for intestinal delivery |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2637612B1 (fr) * | 1988-10-06 | 1993-09-10 | Pasteur Institut | Sequences de nucleotides codant pour une proteine a activite ureasique |
US5234910A (en) * | 1989-07-18 | 1993-08-10 | University Hospital | Acid inhibitor of bacterial origin |
US5258178A (en) * | 1990-07-30 | 1993-11-02 | Abbott Laboratories | Method and product for the treatment of gastric disease |
ATE180280T1 (de) * | 1991-03-05 | 1999-06-15 | Wellcome Found | Expression rekombinanter proteine in attenuierten bakterien |
US5262156A (en) * | 1991-08-12 | 1993-11-16 | Hycor Biomedical, Inc. | Antigenic compositions and their use for the detection of Helicobacter pylori |
ATE273021T1 (de) * | 1992-02-26 | 2004-08-15 | Univ Vanderbilt | Gereinigtes vakuolisierendes toxin aus helicobacter pylori und methoden zu dessen verwendung |
MX9301706A (es) * | 1992-04-13 | 1994-05-31 | Oravax Inc | Composicion de vacuna para el tratamiento de la infeccion por helicobacter. |
US5420014A (en) * | 1992-04-30 | 1995-05-30 | Auspharm International Ltd. | Rapid in vitro test for helicobacter pylori using saliva |
WO1994006474A1 (en) * | 1992-09-16 | 1994-03-31 | Galagen Inc. | ANTIBODY TREATMENT OF $i(HELICOBACTER PYLORI) |
US5972336A (en) * | 1992-11-03 | 1999-10-26 | Oravax Merieux Co. | Urease-based vaccine against helicobacter infection |
US5871749A (en) * | 1993-07-27 | 1999-02-16 | Csl Limited | Therapeutic treatment of H. pylori associated gastroduodenal disease |
US6191268B1 (en) * | 1993-12-17 | 2001-02-20 | Dana-Farber Cancer Institute | Compositions and methods relating to DNA mismatch repair genes |
FR2719998B1 (fr) * | 1994-04-08 | 1996-09-27 | Pasteur Merieux Serums Vacc | Composition immunisante anti-hélicobacter pylori à base de catalase. |
AUPM612494A0 (en) * | 1994-06-08 | 1994-06-30 | Csl Limited | Treatment or prevention of helicobacter infection |
US5498528A (en) * | 1994-06-10 | 1996-03-12 | King; Wing | Detection of helicobacter pylori |
US5610060A (en) * | 1994-06-24 | 1997-03-11 | The United States Of America As Represented By The Department Of Health And Human Services | Isolated Helicobacter hepaticus |
US5837240A (en) * | 1995-04-28 | 1998-11-17 | Oravax-Merieux Co. | Multimeric, recombinant urease vaccine |
AR003125A1 (es) * | 1995-06-01 | 1998-07-08 | Astra Ab | Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en la |
EP0745674B1 (de) * | 1995-06-02 | 2006-07-05 | Eisai Co., Ltd. | Helicobacter Polypeptide, deren Herstellung und Verwendung |
US5939300A (en) * | 1996-07-03 | 1999-08-17 | Diversa Corporation | Catalases |
-
1994
- 1994-06-08 AU AUPM6124A patent/AUPM612494A0/en not_active Abandoned
-
1995
- 1995-06-08 JP JP8500091A patent/JPH10500958A/ja active Pending
- 1995-06-08 KR KR1019960706972A patent/KR100368475B1/ko not_active IP Right Cessation
- 1995-06-08 AT AT95920717T patent/ATE279940T1/de not_active IP Right Cessation
- 1995-06-08 NZ NZ287385A patent/NZ287385A/xx not_active IP Right Cessation
- 1995-06-08 EP EP95920717A patent/EP0771214B1/de not_active Expired - Lifetime
- 1995-06-08 WO PCT/AU1995/000335 patent/WO1995033482A1/en active IP Right Grant
- 1995-06-08 DE DE69533673T patent/DE69533673T2/de not_active Expired - Fee Related
-
1996
- 1996-08-15 US US08/695,987 patent/US6005090A/en not_active Expired - Fee Related
-
1998
- 1998-01-07 US US09/004,014 patent/US6630582B1/en not_active Expired - Fee Related
-
1999
- 1999-10-20 US US09/421,238 patent/US6468545B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AUPM612494A0 (en) | 1994-06-30 |
EP0771214A4 (de) | 1998-07-29 |
EP0771214A1 (de) | 1997-05-07 |
JPH10500958A (ja) | 1998-01-27 |
WO1995033482A1 (en) | 1995-12-14 |
EP0771214B1 (de) | 2004-10-20 |
US6468545B1 (en) | 2002-10-22 |
DE69533673D1 (de) | 2004-11-25 |
DE69533673T2 (de) | 2006-03-09 |
KR100368475B1 (ko) | 2003-04-11 |
US6630582B1 (en) | 2003-10-07 |
KR970703164A (ko) | 1997-07-03 |
NZ287385A (en) | 1998-10-28 |
US6005090A (en) | 1999-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE279940T1 (de) | Behandlung und prävention von helicobacter- infektionen | |
ATE229978T1 (de) | Helicobacter proteine und impstoffe | |
AU7144901A (en) | Human papilloma virus treatment | |
NO963508L (no) | Urease-basert vaksine og behandling av Helicobacter-infeksjon | |
EP0915648A4 (de) | ||
HU901585D0 (en) | Method for treatment of viral infections using functional derivatives of icam-1 | |
ATE222930T1 (de) | Antigene arznei zur behandlung oder vorbeugung | |
HK1005541A1 (en) | Treatment of helicobacter associated gastroduodenal disease | |
TR199900211T2 (xx) | Mupirosin ve klorheksidin'den olu�an bile�im. | |
HU9700023D0 (en) | Pyridyl-thio-compounds, their application again helicobacter bacterium | |
ATE258057T1 (de) | Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen | |
WO2001040473A3 (en) | Pseudomonas aeruginosa antigens | |
AU3439799A (en) | Immunization against and treatment for infection by (h.pylori) | |
LU90378I2 (fr) | Tetravac | |
HK1002658A1 (en) | Imidazopyridine-azolidinones their preparation and pharmaceutical use | |
ATE108335T1 (de) | Kit oder zusammensetzung zur vorbeugung oder behandlung von hiv-1 infektionen. | |
AU673344B2 (en) | Vaccines based on streptokinase | |
ATE132375T1 (de) | Neuramidase und glulaktoseoxidase als vaccinadjuvans | |
CA2191440A1 (en) | Treatment and prevention of helicobacter infection | |
NZ331674A (en) | Use of antigenic preparations comprising Helicobacter catalase for treating or preventing Helicobacter infection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |